Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingtai Capsule is a Traditional Chinese Medicine (TCM) herbal formulation developed by Shaanxi Dongtai Pharmaceutical. It is primarily indicated for the treatment of cervical spondylotic radiculopathy and associated shoulder pain. Administered orally in capsule form, the medication is designed to alleviate symptoms such as neck stiffness, radiating pain, and limb numbness, which are characteristic of nerve root compression in the cervical spine. In TCM theory, such formulations typically work by promoting blood circulation, resolving blood stasis, and dredging the meridians to relieve pain and inflammation. Although it has been tracked in pharmaceutical pipelines for these indications, recent reports indicate a lack of clinical progress, suggesting that its development may be stalled or discontinued.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jingtai Capsule.